title: Hokusai-VTE: Edoxaban for the treatment of venous thromboembolism.
abstract: Venous thromboembolism is associated with a high morbidity and, if left untreated, may progress to fatal outcome. The standard treatment of venous thromboembolism consists of heparin followed by long-term treatment with a vitamin K antagonist. However, the use of vitamin K antagonist has several inherent problems and practical challenges. These challenges have prompted the search for new oral anticoagulant drugs including direct factor Xa inhibitors (e.g., rivaroxaban, apixaban and edoxaban) and thrombin inhibitors (e.g., dabigatran). To date, results for dabigatran, rivaroxaban, apixaban, for the treatment of VTE have been published. Recently, results of the 4th new oral anticoagulant agent, edoxaban, have been published in the Hokusai-VTE study. This review discusses the Hokusai-VTE study with special emphasis on its salient features (compared to other new oral anticoagulant studies) in addition to an overview on some key lessons learnt.
authors.affiliation: Aswan Heart Centre, Aswan, Egypt.
authors.forename: Karim
authors.initials: K
authors.lastname: Said
references.citation: N Engl J Med. 2009 Dec 10;361(24):2342-52
references.pmid: 19966341
references.citation: Mayo Clin Proc. 2013 May;88(5):495-511
references.pmid: 23639500
references.citation: Circulation. 2003 Jun 17;107(23 Suppl 1):I22-30
references.pmid: 12814982
references.citation: N Engl J Med. 2010 Dec 23;363(26):2499-510
references.pmid: 21128814
references.citation: Semin Thromb Hemost. 2002 Jun;28 Suppl 2:3-13
references.pmid: 12073175
references.citation: N Engl J Med. 1986 Oct 30;315(18):1109-14
references.pmid: 3531862
references.citation: Lancet. 1999 Apr 24;353(9162):1386-9
references.pmid: 10227218
references.citation: N Engl J Med. 2013 Oct 10;369(15):1406-15
references.pmid: 23991658
references.citation: Clin Ther. 2004 Jul;26(7):1149-59
references.pmid: 15336480
references.citation: Drugs. 2011 Aug 20;71(12):1503-26
references.pmid: 21861537
references.citation: N Engl J Med. 2013 Aug 29;369(9):799-808
references.pmid: 23808982
references.citation: N Engl J Med. 2012 Apr 5;366(14):1287-97
references.pmid: 22449293
references.citation: J Vasc Surg. 1992 Nov;16(5):707-14
references.pmid: 1433658
references.citation: Haematologica. 2007 Feb;92(2):199-205
references.pmid: 17296569
references.citation: Eur J Intern Med. 2012 Dec;23(8):692-5
references.pmid: 23095463
references.citation: Adv Ther. 2010 Sep;27(9):623-33
references.pmid: 20680533
references.citation: Chest. 2008 Jun;133(6 Suppl):257S-298S
references.pmid: 18574268
references.citation: Chest. 2012 Feb;141(2 Suppl):7S-47S
references.pmid: 22315257
references.citation: Thromb Haemost. 2002 Sep;88(3):407-14
references.pmid: 12353068